FB Pixel no scriptSeed-stage medtech startup See-Mode raises $1m | KrASIA

Seed-stage medtech startup See-Mode raises $1m

Written by Robin Moh Published on 

And they may save some lives.

Singapore-based medtech startup See-Mode has secured US$1 million in a seed financing round led by Cocoon Capital. Other investors include Australia-based BlackBird Ventures and SGInnovate. Late last year, the Singapore-based Cocoon Capital launched a US$20 million fund to focus on deep tech, fintech, and medtech startups in the Southeast Asia region.

See-Mode was founded in 2017 by two biomedical engineers, Milad Mohammadzadeh and Sadaf Monajemi, to improve the diagnostic process for stroke patients. The company’s medical software is designed to assist clinicians interpret ultrasound images and assess patients’ blood flow patterns based on a CT scan or MRI. It will also allow doctors to detect vulnerable plaques, which was a service that was previously inaccessible in clinics.

According to the World Stroke Organisation, there are 15 million people suffer from strokes each year, more than one-third of which end up dying as a result. In Singapore, one in three deaths between 2015 and 2017 was due to heart diseases or strokes, according to the country’s Ministry of Health.

See-Mode counts the National University Hospital, Changi General Hospital, and the National Neuroscience Institute of Singapore as partners. The company will also be launching a clinical study with hospitals in the United States and Australia.

Editor: Brady Ng


You might like these

  • Insights

    Blind man regains sight after receiving first artificial cornea implant by Israel’s CorNeat Vision



    19 Jan 2021    11:35 AM

KrASIA InsightsKrASIA Insights

  • With over 22 million users, Facebook was the favored social network in Myanmar. Now, it is “temporally” banned in the country, and some people feel dazed.


    Facebook was the internet in Myanmar. What happens now that it’s banned? | Tech in Culture

    By Stephanie Pearl Li

    24 Feb 202110:38 AM

Most PopularMost Popular

See All